|
Livanova usa, inc.Submits this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation, based on information that livanova has obtained, but may not have been able to investigate or verify prior to the date the report was required by the fda.This report does not constitute an admission, or a conclusion by fda or anyone else, that the device, livanova, or livanova's employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects¿ or "malfunctions¿.These words are incorporated into the fda 3500a medwatch form by the fda, and livanova objects to their use.
|
|
It was reported that the patient's battery life is now at ifi (intensfied followup indicator) =yes and their settings were provided as 2ma/21sec/3min.The patient's device was just implanted on (b)(6) 2024 and in (b)(6) 2025 their battery was at 75-100%.Internal data from the generator was received and reviewed.The device history records for the generator were reviewed.The generator passed all specifications, including quality control inspection, and showed no non-conformities, prior to its release into the field for distribution.No other relevant information has been received to date.
|